(Q43807571)

27 November 2017

title

Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection (English)

1 reference

27 November 2017

Kim D

1

1 reference

27 November 2017

Wang L

2

1 reference

27 November 2017

Caldwell CG

3

1 reference

27 November 2017

Chen P

4

1 reference

27 November 2017

Finke PE

5

1 reference

27 November 2017

Oates B

6

1 reference

27 November 2017

MacCoss M

7

1 reference

27 November 2017

Mills SG

8

1 reference

27 November 2017

Malkowitz L

9

1 reference

27 November 2017

Gould SL

10

1 reference

27 November 2017

DeMartino JA

11

1 reference

27 November 2017

Springer MS

12

1 reference

27 November 2017

Hazuda D

13

1 reference

27 November 2017

Miller M

14

1 reference

27 November 2017

Kessler J

15

1 reference

27 November 2017

Danzeisen R

16

1 reference

27 November 2017

Carver G

17

1 reference

27 November 2017

Carella A

18

1 reference

27 November 2017

Holmes K

19

1 reference

27 November 2017

Lineberger J

20

1 reference

27 November 2017

Schleif WA

21

1 reference

27 November 2017

Emini EA

22

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

27 November 2017

published in

1 reference

27 November 2017

volume

11

1 reference

27 November 2017

issue

24

1 reference

27 November 2017

page(s)

3099-3102

1 reference

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Chemokine receptors and chemokines in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Opportunities for novel therapeutic agents acting at chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Chemokine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

"Diversomers": an approach to nonpeptide, nonoligomeric chemical diversity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

Combinatorial chemistry of hydantoins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900654-0

7 January 2021

10.1016/S0960-894X(01)00654-0

Identifiers

DOI

1 reference

27 November 2017

1 reference